Effectiveness of Nutritional Resources for Milk Donors
Launched by UNIVERSITY OF ROEHAMPTON · Jun 24, 2025
Trial Information
Current as of June 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how helpful specially designed nutrition information is for women who donate breast milk. Researchers have found that donor milk in the UK often lacks important nutrients called omega-3 and omega-6 fatty acids, especially one called DHA, which are vital for a baby’s brain and immune system development. The study aims to see if giving milk donors clear, easy-to-follow nutrition advice can improve the DHA levels in their breast milk. They will also check if giving donors feedback about their milk’s DHA content encourages them to make changes that boost these important nutrients.
Women who have recently given birth (between 6 and 8 weeks ago) and are new donors at the Countess of Chester Hospital milk bank may be eligible to join. Participants should be able to understand English well enough to read information and complete questionnaires, should not be taking high-dose omega-3 supplements, and should have a body mass index (BMI) under 30. If you take part, you’ll receive nutritional guidance developed with input from healthcare experts and donors, and your milk’s DHA levels will be monitored. If this approach works, it could help improve the quality of donor milk across the UK and support breastfeeding mothers more broadly.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • New donors from the Countess of Chester Hospital milk bank
- • Between six to eight weeks of giving birth
- Exclusion Criteria:
- • Insufficient comprehension of English to understand the information sheet and consent form and complete the questionnaires
- • Currently taking omega-3 PUFA dietary supplements providing greater than 200 mg DHA per day
- • Body Mass Index (BMI) ≥30 kg/m2
About University Of Roehampton
The University of Roehampton is a distinguished academic institution committed to advancing research and education in various fields, including health and clinical sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research initiatives aimed at improving patient outcomes and contributing to the broader medical community. With a focus on ethical standards and rigorous scientific methodologies, the University of Roehampton fosters collaborations that drive impactful discoveries and enhance evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Simon Dyall, PhD
Study Chair
University of Roehampton
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported